Community
Carbohydrate classroom reaches Northwest Territories and Northern British Columbia
High school teachers become students for one day to learn about glycoscience
A combination therapy for treating severe neurological childhood disorders
GlycoNet researchers propose new ways to tackle a rare, fatal genetic disease of children
Toronto start-up built upon GlycoNet Investigator’s technology raises $10.3 million to treat post-surgery pain
Molly Shoichet, founder of AmacaThera, talks about translating ideas from the lab to the market in the Globe and Mail.
More stories
- All
- Awards
- Community
- Network Profile
- Press Release
- Research Highlight
GlycoNet launches equity, diversity, and inclusion program to achieve a more diverse and productive research community
The training program will equip participants with knowledge about EDI fundamentals and unconscious bias.
GlycoNet researchers identify drugs with potential to stop plaque buildup in arteries
Findings could lead to better treatments for cardiovascular disease—the second leading cause of death in Canada
Sugar research might help answer the unanswered in cancer
Canadian scientists from GlycoNet are making strides in cancer research through gaining a deeper understanding of sugars in our body
New glycomics research investments from GlycoNet to facilitate a resilient recovery for Canada
$1.3 million in funding to support new sugar research to tackle unmet needs in national healthcare
GlycoNet Investigator receives award to advance technologies for ‘Universal Donor’ O type blood
Dr. Stephen Withers is one of nine recipients of the 2020 Innovation to Commercialization Program Award from the Michael Smith Foundation of Health Research.
A better way to freeze stem cells and tissue
The best technological innovations are inspired by nature.
GlycoNet Investigator named to the Order of Canada
Dr. Lori West receives one of Canada’s highest honours to recognize her leadership in organ transplantation and donation.
Top 10 stories from GlycoNet in 2020
A year in review in glycomics innovations.
GlycoNet start-up PanTHERA CryoSolutions receives up to $4 million investment to advance technologies in regenerative medicine
The made-in-Canada technology is revolutionizing the cryopreservation of cell and tissues.
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 78-492-6204
Fax: 780-492-4147
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.
English 
French